Project Management
Drive Efficient and Successful GCP-Compliant Trials with Our Expert Project Management, from Start to Finish
We are all-inclusive partner in excellence for End –to-End Clinical Trial Support
Zenovel is committed to providing pharmaceutical quality control companies unparalleled support through our broad spectrum of project management services.
Sponsor of the study is ethically responsible for the safe conduct of the trial, even though the trial or study is currently being outsourced to CRO for additional technical support. To fulfil these responsibilities, all stakeholders must remain actively engaged in constant interaction and association with CRO. Zenovel acknowledges this primary obligation from the sponsors / client and pledges that all administrative and technical activities will be conducted by the CRO in accordance with the statement of work and GCP standards from the outset.
- Zenovel’s PM Services
Zenovel’s project management services cover every aspect of clinical trial management ensuring comprehensive support from start to finish which includes Site Identification, Feasibility, Audit and Selection through budget finalisation, Protocol Review, Complete coordination and Monitoring of Study and for Report submission.
- Project Management Services
We offer range of services depending upon the phase of your trial
- Pre Study
- Site/CRO Identification
- Feasibility
- Audit
- Selection and Study Budget Finalisation
- Protocol writing and review
- Selection of appropriate design of the study,
- Regulatory insight,
- Controlled correspondence with regulatory
- Complete Pre-Approval support
- During Study
- Complete Coordination with CRO/Site personnel.
- Timeline Management and Slotting,
- IMP Accountability verification,
- Complete Project Management of entire trial,
- Complete Monitoring with Scope agreed upon with Client.
- Risk-Mitigation plan assessment.
- Post Study
- Retrospective Data review and Verification,
- Independent QA visits
- Report review
- Close out
- Pre-Inspection Readiness support,
- Handling of Regulatory queries
People Also Ask (FAQs)
Yes. Even when a Contract Research Organization (CRO) is conducting operational activities, sponsors often outsource independent project management to ensure proper oversight, coordination, and risk control. Independent project management helps maintain alignment between sponsors, CROs, vendors, and study sites while ensuring regulatory compliance and timely study execution.
Risk management is a critical component of clinical trial project management. Project teams perform risk identification, evaluation, and mitigation planning to address potential issues related to patient safety, protocol deviations, recruitment delays, and data quality. Proactive risk management helps maintain trial integrity and regulatory compliance.
Yes. Zenovel provides flexible clinical trial project management support for early-stage studies, pilot trials, and small-scale clinical research programs. Their team helps sponsors manage timelines, coordinate stakeholders, and maintain regulatory compliance even for limited-scope or early-phase projects.
Zenovel focuses on a proactive project management approach that combines regulatory expertise, risk-based planning, and close coordination with CROs and study sites. This ensures better oversight of study timelines, improved communication between stakeholders, and efficient handling of operational challenges during clinical trials.
Zenovel ensures smooth collaboration by implementing structured communication plans, performance tracking systems, and regular project review meetings. Their project management team monitors study milestones, vendor performance, and site activities to maintain alignment with study objectives and regulatory requirements.
Blogs and news
Our Latest Article
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
